Toward a genetic analysis of tumor rejection antigens
- PMID: 1546558
- DOI: 10.1016/s0065-230x(08)60295-x
Toward a genetic analysis of tumor rejection antigens
Similar articles
-
Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.Immunol Res. 1990;9(4):298-313. doi: 10.1007/BF02935529. Immunol Res. 1990. PMID: 2089075 Review. No abstract available.
-
Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.Important Adv Oncol. 1994:53-69. Important Adv Oncol. 1994. PMID: 8206495 Review. No abstract available.
-
Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.Jpn J Cancer Res. 1991 Jul;82(7):841-7. doi: 10.1111/j.1349-7006.1991.tb02711.x. Jpn J Cancer Res. 1991. PMID: 1679057 Free PMC article.
-
Mutagen-induced antigenic variants of tumor cells.Symp Fundam Cancer Res. 1986;38:139-48. Symp Fundam Cancer Res. 1986. PMID: 3489258 No abstract available.
-
Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.Cancer Res. 1989 Jan 1;49(1):38-43. Cancer Res. 1989. PMID: 2783244
Cited by
-
Immune selection in neoplasia: towards a microevolutionary model of cancer development.Br J Cancer. 2000 Jun;82(12):1900-6. doi: 10.1054/bjoc.2000.1206. Br J Cancer. 2000. PMID: 10864195 Free PMC article. Review.
-
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.J Exp Med. 1995 Sep 1;182(3):689-98. doi: 10.1084/jem.182.3.689. J Exp Med. 1995. PMID: 7544395 Free PMC article.
-
Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.Clin Exp Metastasis. 1994 Jan;12(1):73-83. doi: 10.1007/BF01784336. Clin Exp Metastasis. 1994. PMID: 8287623
-
Therapeutic vaccination with tumor cells that engage CD137.J Mol Med (Berl). 2003 Feb;81(2):71-86. doi: 10.1007/s00109-002-0413-8. Epub 2003 Feb 8. J Mol Med (Berl). 2003. PMID: 12601523 Review.
-
Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide.Cancer Immunol Immunother. 1994 Aug;39(2):105-16. doi: 10.1007/BF01525316. Cancer Immunol Immunother. 1994. PMID: 7519125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources